Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response
Conditions: Heart Transplant Infection; CMV Infection Intervention: Diagnostic Test: ELISPOT IFN-γ assay Sponsors: Hospital Universitari de Bellvitge; Instituto de Salud Carlos III; Sociedad Española de Cardiología Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Clinical Trials | Heart | Heart Transplant | Research | Transplant Surgery | Transplants